Video
Revumenib Meets CR/CRh End Point in NPM1+ R/R AML
Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
Personalized Initiatives Empower Patients to Actively Participate in Cancer Research
Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress
FDA Approval Sought for Sunvozertinib in Pretreated EGFR Exon 20+ Advanced NSCLC
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors
Transposon-Based BAFF CAR T Cells Show Early Efficacy, Safety in R/R Non-Hodgkin Lymphoma
Piecing Together the Proper BTK Usage in CLL
Real-World Experience With CAR T Varies From Trials in DLBCL
TAB-Follicular Lymphoma